Your browser doesn't support javascript.
loading
Vav Proteins Are Key Regulators of Card9 Signaling for Innate Antifungal Immunity.
Roth, Susanne; Bergmann, Hanna; Jaeger, Martin; Yeroslaviz, Assa; Neumann, Konstantin; Koenig, Paul-Albert; Prazeres da Costa, Clarissa; Vanes, Lesley; Kumar, Vinod; Johnson, Melissa; Menacho-Márquez, Mauricio; Habermann, Bianca; Tybulewicz, Victor L; Netea, Mihai; Bustelo, Xosé R; Ruland, Jürgen.
Afiliação
  • Roth S; Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 München, Germany; Chirurgische Klinik, Universitätsklinikum Heidelberg, Ruprecht-Karls-Universität, 69120 Heidelberg, Germany.
  • Bergmann H; Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 München, Germany.
  • Jaeger M; Department of Medicine, Radboud University, Medical Centre, 6500 HB Nijmegen, the Netherlands; Radboud Center for Infectious Diseases, 6500 HB Nijmegen, the Netherlands.
  • Yeroslaviz A; Max Planck Institute of Biochemistry, Research Group Computational Biology, 82152 Martinsried, Germany.
  • Neumann K; Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 München, Germany.
  • Koenig PA; Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 München, Germany.
  • Prazeres da Costa C; Institut für Medizinische Mikrobiologie, Immunologie, und Hygiene, Klinikum rechts der Isar, Technische Universität München, 81675 München, Germany.
  • Vanes L; Francis Crick Institute, London NW1 1AT, UK.
  • Kumar V; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, 9700 RB, the Netherlands.
  • Johnson M; Duke University Medical Center, Duke Box 102359, Durham, NC 27710, USA.
  • Menacho-Márquez M; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007 Salamanca, Spain.
  • Habermann B; Max Planck Institute of Biochemistry, Research Group Computational Biology, 82152 Martinsried, Germany.
  • Tybulewicz VL; Francis Crick Institute, London NW1 1AT, UK; Department of Medicine, Imperial College, London W12 0NN, UK.
  • Netea M; Department of Medicine, Radboud University, Medical Centre, 6500 HB Nijmegen, the Netherlands.
  • Bustelo XR; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007 Salamanca, Spain; Centro de Investigacion Biomedica en Red-Oncologia, Carlos III Health Institute, Spain.
  • Ruland J; Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 München, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany. Electronic address: j.rul
Cell Rep ; 17(10): 2572-2583, 2016 12 06.
Article em En | MEDLINE | ID: mdl-27926862
ABSTRACT
Fungal infections are major causes of morbidity and mortality, especially in immunocompromised individuals. The innate immune system senses fungal pathogens through Syk-coupled C-type lectin receptors (CLRs), which signal through the conserved immune adaptor Card9. Although Card9 is essential for antifungal defense, the mechanisms that couple CLR-proximal events to Card9 control are not well defined. Here, we identify Vav proteins as key activators of the Card9 pathway. Vav1, Vav2, and Vav3 cooperate downstream of Dectin-1, Dectin-2, and Mincle to engage Card9 for NF-κB control and proinflammatory gene transcription. Although Vav family members show functional redundancy, Vav1/2/3-/- mice phenocopy Card9-/- animals with extreme susceptibility to fungi. In this context, Vav3 is the single most important Vav in mice, and a polymorphism in human VAV3 is associated with susceptibility to candidemia in patients. Our results reveal a molecular mechanism for CLR-mediated Card9 regulation that controls innate immunity to fungal infections.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Candida / Lectinas Tipo C / Proteínas Adaptadoras de Sinalização CARD / Candidemia / Imunidade Inata Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Candida / Lectinas Tipo C / Proteínas Adaptadoras de Sinalização CARD / Candidemia / Imunidade Inata Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha